HomeCMPX • NASDAQ
add
Compass Therapeutics Inc.
Previous close
$1.59
Day range
$1.43 - $1.62
Year range
$0.77 - $2.33
Market cap
197.44M USD
Avg Volume
496.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.24M | 2.62% |
Net income | -10.48M | -5.19% |
Net profit margin | — | — |
Earnings per share | -0.08 | 0.00% |
EBITDA | -12.10M | -2.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 135.40M | -17.29% |
Total assets | 149.15M | -12.28% |
Total liabilities | 10.75M | 7.61% |
Total equity | 138.40M | — |
Shares outstanding | 137.59M | — |
Price to book | 1.57 | — |
Return on assets | -20.08% | — |
Return on capital | -20.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.48M | -5.19% |
Cash from operations | -11.05M | -86.61% |
Cash from investing | 29.02M | 70.20% |
Cash from financing | -2.00K | -109.52% |
Net change in cash | 17.96M | 61.15% |
Free cash flow | -7.99M | -242.32% |
About
Founded
2014
Headquarters
Website
Employees
32
